NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ariana Pharma

Ariana Pharma

Private
ParisHealthcare & Life Scienceshttps://www.arianapharma.com/

Last Round

Grant

Apr 16, 2024

Total Funding Raised

$2.35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ariana Pharma is a biotechnology company that develops AI-driven software and decision support systems to optimize clinical trials and drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Revenue Share

AI Layer

Application

Keywords

explainable AIxAIdrug discoverybiomarker identificationclinical trial designprecision medicineformal concept analysistherapeutic decision supportclinical data analysispatient stratificationAI drug discoverybiotech AIreal-world evidenceRWEoncology AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ariana Pharma Comparables

Compare Ariana Pharma with similar companies based on industry and business-model similarity.

Ariana Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BullFrog AI Holdings, Inc.
77%
BenevolentAI
76%
Certara
67%

Ariana Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 16, 2024
GrantMar 1, 2024
Series AJul 8, 2008
SeedNov 3, 2005

Ariana Pharma Investors

Notable investors and investment history

Ariana Pharma investors
InvestorRounds
Eurostars SME programmeGrant
Aventis FoundationSeed
Institut PasteurSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors grew 33% MoM.

  • Apr 16, 2024

    $3.2M grant received from Eurostars SME programme.

Ariana Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ariana Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ariana Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range31
Year Founded2003
Last FundingApr 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.